WO2007070957A1 - Process and apparatus for generating particles - Google Patents

Process and apparatus for generating particles Download PDF

Info

Publication number
WO2007070957A1
WO2007070957A1 PCT/AU2006/001951 AU2006001951W WO2007070957A1 WO 2007070957 A1 WO2007070957 A1 WO 2007070957A1 AU 2006001951 W AU2006001951 W AU 2006001951W WO 2007070957 A1 WO2007070957 A1 WO 2007070957A1
Authority
WO
WIPO (PCT)
Prior art keywords
particles
process according
liquid
transducer element
vibration
Prior art date
Application number
PCT/AU2006/001951
Other languages
French (fr)
Inventor
James Robert Friend
Lesile Yu-Ming Yeo
Original Assignee
Monash University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005907181A external-priority patent/AU2005907181A0/en
Application filed by Monash University filed Critical Monash University
Publication of WO2007070957A1 publication Critical patent/WO2007070957A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05BSPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B17/00Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups
    • B05B17/04Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods
    • B05B17/06Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations
    • B05B17/0607Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D1/00Evaporating
    • B01D1/16Evaporating by spraying
    • B01D1/18Evaporating by spraying to obtain dry solids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/18Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic using a vibrating apparatus

Definitions

  • the present invention relates to a process and apparatus for generating particles.
  • biopharmaceuticals A new generation of therapeutics known as biopharmaceuticals includes biologic drugs, proteins, polynucleotides and liposomes.
  • biopharmaceuticals the efficiency of biopharmaceuticals is limited by their generally poor update in the human body.
  • One approach to address the very low cell transection efficiencies of biopharmaceutical is to administer large doses. However, this can lead to unwanted side-effects such as toxicity and multidrug resistance, as well as the economic factors of higher expense per dose and the need for greater biopharmaceutical production.
  • the two steps that limit biopharmaceutical uptake in the body are: (i) the cellular uptake of the biopharmaceutical, and (ii) the migration of the biopharmaceutical into the cell nucleus.
  • a process for generating particles including: applying an ultrasonic signal to at least one electrode of a piezoelectric transducer element to generate vibrations in said transducer element; and applying a liquid to a surface of said transducer element, said liquid including a particle forming component and a carrier component; whereby the vibration of said transducer element generates droplets of said liquid to form substantially solid particles by evaporation of at least part of said carrier component.
  • the ultrasonic signal has a frequency of at least about 1 MHz.
  • said particles have a diameter of less than about 1000 nm.
  • the carrier component is substantially volatile.
  • the vibration of said transducer element is such that the formed particles have a substantially monodisperse size distribution.
  • the transducer element may include electrodes located on opposing surfaces of a piezoelectric material to excite piston mode vibration of said material.
  • said vibration is at a frequency of at least about 100 to 500 MHz.
  • said vibration is at a resonance frequency of said material.
  • the transducer element may include the electrodes located on one surface of said material to excite surface acoustic waves in said surface.
  • the ultrasonic signal applied to the electrode may be at a frequency of at least about 8 MHz.
  • the diameter of said droplets is less than about 6000 nm.
  • the diameter of said particles is less than about 250 nm.
  • the diameter of said particles is less than about 50 nm.
  • said particle forming component of said liquid includes a polymer.
  • said polymer is suitable for drug delivery to a human being.
  • said particle forming component of said liquid may include a metal or ceramic.
  • said liquid may include a drug.
  • said liquid may include a biopharmaceutical substance.
  • said particles may include a liquid encapsulated within a solid.
  • the present invention also provides an apparatus for generating particles, including: a transducer element including a piezoelectric material having at least one electrode located on one or more surfaces of said material; a signal generator connected to said electrode to apply an ultrasonic signal to said electrodes, thereby generating vibrations in said material; whereby the vibration of said material generates droplets of a liquid applied to a surface of said material, the liquid including a particle forming component and a carrier component such that the droplets form substantially solid particles by evaporation of at least part of said carrier component.
  • the apparatus includes a dispensing component for dispensing said liquid to said surface.
  • the ultrasonic signal has a frequency of at least about 1 MHz.
  • said particles have a diameter of less than about 1000 nm.
  • the carrier component is substantially volatile.
  • the vibration of said material is such that the formed particles have a substantially monodisperse size distribution.
  • the electrodes may be on opposing surfaces of said material to excite piston mode vibration of said material.
  • said vibration is at a frequency of at least about 100 to 500 MHz.
  • said vibration is a resonance frequency of said material.
  • the electrodes may be located on one surface of said material to excite surface acoustic waves in said surface.
  • the ultrasonic signal applied to the electrode may be at a frequency of at least about 8 MHz.
  • the diameter of said droplets is less than about 6000 nm.
  • the diameter of said particles is less than about 250 nm.
  • the diameter of said particles is less than about 50 nm.
  • said particle forming component of said liquid includes a polymer.
  • said polymer is suitable for drug delivery to a human being.
  • said particle forming component of said liquid may include a metal or ceramic.
  • said liquid may include a drug.
  • said liquid may include a biopharmaceutical substance.
  • Figure 1 is a schematic diagram of a preferred embodiment of an apparatus for producing nanoparticles
  • Figure 2 is a flow diagram of a preferred embodiment of a process for producing nanoparticles using the apparatus
  • Figures 3 and 4 are graphs of particle size distribution produced by the atomizer using vibration velocities of 1.0 and 1.4 m/s, respectively;
  • Figure 5 is a schematic diagram of a piezoelectric transducer of the SAW atomizer in accordance with a second preferred embodiment of the invention
  • Figure 6 is an image of a photolithographic mask used to define electrodes of a SAW atomizer in accordance with Figure 5;
  • Figures 7 and 8 are images of portions of the photolithographic mask used to define pairs of interdigitated electrodes for the SAW atomizer
  • Figure 9 is a graph of particle size distribution produced by the SAW atomizer.
  • Figure 10 is a scanning electron microscope image of agglomerated particles of zeolite produced by the SAW atomizer, each particle having a diameter of about 100 nm.
  • an apparatus for generating particles includes a piezoelectric transducer element 101 in the form of a cylindrical disc 102 of a hard piezoelectric material such as lead zirconate titanate (PZT) and having a diameter of about 20 to 30 mm and a thickness of about 1 mm.
  • the apparatus also referred to herein as an atomizer, is described herein in relation to an atomization process, as shown in Figure 2, that generates substantially solid particles, via the formation of nanoscale droplets of a liquid that includes a particle forming component and a carrier component.
  • step 202 500-nm thick layers of platinum (Pt) metal are deposited onto the opposing planar faces of the disc 102 to provide electrodes 104 for the atomizer.
  • the PZT disc 102 is then polarized by applying a 20 kV/cm electric field to orient the electric domains within the ceramic PZT disc 102 along the thickness direction of the disc 102.
  • the electrodes 104 are subsequently connected to outputs of respective polarities of a Radio Frequency (RF) signal generator 106.
  • RF Radio Frequency
  • the RF signal generator 106 drives the PZT transducer element 101 with a sinusoidal signal having an ultrasonic frequency of at least about 1 MHz, thereby causing the opposing planar faces of the transducer element 101 to vibrate with a relatively constant and in-phase piston-like motion across each planar face of the transducer element 101.
  • the disk 102 is preferably driven in either its fundamental (being in this case 1.645 MHz) or first harmonic (5.345 MHz) thickness mode of vibration.
  • a drop of a desired fluid is applied to the underside or downward directed face 108 of the transducer element 101 from a syringe 110 or other form of liquid pump, using a supply tube 112 to conduct the fluid from the syringe 110 to the transducer element 101.
  • the liquid applied to the face of the transducer element 101 includes a particle forming component and a carrier component.
  • the particle forming component can be any substance that can be dissolved in the carrier component and that solidifies to a substantial extent upon removal of the carrier component. Examples of suitable particle forming components include polymers, metals, and ceramics.
  • the particle forming component is preferably a polymer, and more preferably a polymer suitable for drug delivery to a human being, being a physiologically acceptable polymer that biodegrades into non-harmful products such as natural metabolites or other materials that can be readily cleared from the body on an acceptable time scale.
  • the liquid can also include chemical and/or biological markers to harness cellular transport mechanisms and thereby increase transfection efficiencies into cells.
  • the liquid may also control the release of an encapsulated drug by selective degradation of the polymer matrix upon injection, ingestion or inhalation.
  • the liquid drop 112 on the lower face 108 of the transducer element 102 is atomized, whereby tiny droplets or particles of the liquid are emitted from the surface of the drop 112.
  • the droplets are generated by acoustic radiation transmitted from the PZT element into the liquid applied to the transducer face 108, as described in Robert J. Lang, Ultrasonic atomization of liquids, Journal of the Acoustical Society of America Vol. 34, No. 1 , 1962 (“Lang").
  • the droplets are believed to be generated by surface capillary waves at low power excitation of the PZT element, and by surface instabilities about the crests of these waves at higher power excitation.
  • the atomized droplets or particles 116 fall a distance 118 (being in this case about 8 cm) under gravity to a capture medium 120 contained in a vessel 122 located under the transducer element 101 at step 208, allowing for evaporation of the carrier component of the liquid within the atomized droplets to form substantially solid or hollow, fluid-containing particles.
  • the particles can be monodisperse with diameters on a nanometer-scale.
  • the capture medium contains chemicals to prevent agglomeration of the formed nanoparticles.
  • the capture medium consists of deionized (Dl) water and a hardening agent such as sodium dodecyl sulfate (SDS) at 1 mM, which facilitates the precipitation of the particles 116 in the capture medium 120.
  • the nanoparticle-containing capture medium and hardening agent is then centrifuged at approximately 2500 rpm for 10 minutes in a swinging bucket rotor to remove any large agglomerates that may have formed, due predominantly to accumulation of the hydrophobic polymer at the air-liquid interface. Measurement of the particle size distribution both before and after centrifugation indicates that the distribution and yield of the nanoparticles was unaffected by the centrifuge.
  • a polymeric solution was prepared by dissolving polycaprolactone (PCL), with a molecular weight of 65 000 Dalton in acetone (99.5% purity) to create a feedstock solution of 0.5% PCL weight per volume (w/v).
  • PCL polycaprolactone
  • the feedstock solution pumped onto the face 108 of the transducer element 102 forms a 10-mm diameter droplet with a wetting angle of approximately 30 degrees, maintained through controlled pumping rate of the feedstock solution.
  • the acetone carrier component evaporates very rapidly upon atomization to produce solid particles of the polymer.
  • the resulting particle sizes were measured using a Zetasizer instrument from the UK company Malvern Instruments with Dispersion Technology Software version 4.10b1.
  • the Z-average particle size of each sample is defined as the diameter of the sphere that diffuses at the same speed as the particle being measured.
  • the Malvern system determines Z-average particle size by measuring the Brownian motion of the particles in a sample using dynamic light scattering. The vibration velocity of the surface was monitored using a laser Doppler vibrometer during operation.
  • Figure 3 is a log-linear graph of the particle size frequency distribution under the conditions which resulted in the smallest Z- average particle size observed, 181 nm, with a standard deviation ( ⁇ ) of 6.5 nm.
  • Figure 3 is essentially a monodisperse, symmetrical (on a log-linear scale) frequency distribution 302.
  • a small amount of larger agglomerations 304 which were not removed by the centrifuge are visible in the graph at diameters of approximately 500 to 700 nm.
  • Figure 4 is a graph of the bimodal particle size frequency distribution that was obtained when the vibration velocity was increased to 1.4 m/s.
  • the reduced efficiency of the atomisation process may be caused by overheating of the liquid, causing it to boil away, or by the ejection of far larger droplets from the surface of the drop 114 than at the lower vibration velocity of 1.0 m/s.
  • the efficiency of the atomisation process is also reduced if the concentration of SDS in the capture solution hardening agent is increased to 100 mM. It is believed that the hydrophobic nature of the polymer prevents the creation of a stable emulsification in water, and hence a surfactant is added to assist in stabilizing the nanoparticle/hardening agent solution.
  • the critical micelle concentration (CMC) of SDS in water is approximately 2.5 g/l or 8.7 mM. It was observed that, at concentrations below and above the CMC of SDS in water, e.g. 1 mM and 10 mM, no sedimentation of the nanoparticles occurred. At much higher SDS concentrations, e.g. 100 mM or 11.5 CMC, the particles tended to form larger aggregates that varied greatly in size, as indicated by the larger Z- average particle diameter and larger standard deviation in column 3 of Table 1.
  • nanoparticles of fluid are generated by surface acoustic waves on the surface of a piezoelectric transducer, as described in M. Kurosawa, A. Futami, and T. Higuchi, Characteristics of Liquids Atomization Using Surface Acoustic Wave, Proc. of Transducer 97, Chicago, USA (“Kurosawa”), rather than by piston movement of the entire transducer, as described above.
  • the transducer element 501 includes four interdigitated finger electrode pairs 502,
  • the substrate 506 is cut from a 128 Y-X rotated
  • LiNbO 3 crystal wafer sourced from Roditi UK, Ltd.
  • Electrodes 502 and 503 are connected to respective polarity outputs of the signal generator 106, with the other pair of electrodes 504, 505 being left disconnected, short-circuited, or also connected to the signal generator 106 in the same manner as the first pair pf electrodes 502, 503 to obtain different forms of wave vibration along the crystal surface.
  • the electrodes are defined by photolithography using the quartz mask shown in Figure 6. The mask defines four sets of electrode pairs and thus can be used to produce four surface acoustic wave (SAW) atomizers.
  • SAW surface acoustic wave
  • the upper three rows of electrode pairs are identical and define a simple interdigitated electrode pair configuration as shown in Figure 5.
  • Each electrode is formed by depositing a 5-nm thick adhesion layer of titanium followed by a 250-nm-thick layer of aluminium.
  • the black boxes 604 around the periphery of the mask are used to align cutting lines; the corner boxes 606 demarcate the sides of the top and bottom atomizers and ends of all four atomizers.
  • the smaller boxes 604 along the left and right sides demarcated the dividing lines between the atomizers.
  • Wires (not shown) are attached to the upper and lower bars 608 of each pair of interdigitated finger electrodes to conduct the ultrasonic driving signals to each of the electrode fingers.
  • the Rayleigh waves are essentially isolated to the region where the fingers overlap, and propagate in both directions from each electrode pair. Reflection of the Rayleigh wave generated from the electrodes off the left and right edges is reduced by coating the edges of the LiNbOs crystal with silicone rubber. The left electrode pair and right electrode pair are used together to form
  • Rayleigh surface acoustic waves
  • SAW surface acoustic waves
  • These waves are formed by the inverse piezoelectric effect among the fingers of each electrode pair, where a differential charge between fingers causes distortion of the surface at a speed which matches the speed of sound of the Rayleigh wave divided by the distance between the IDT fingers.
  • the speed of sound of Rayleigh wave along the y-axis of 128 Y-X LiNbO 3 material is 5112 m/s
  • four times the 110-micron inter-finger width is 440 microns, giving a frequency of 11.6 MHz.
  • the RF signal generator 106 drives the lithium niobate element 506 with a sinusoidal signal having an ultrasonic frequency of at least about 1 MHz, thereby causing the planar faces of the transducer element 506 to vibrate with a relatively constant sinusoidal motion between and within electrodes 502 to 505, perpendicular to the planar face and along a direction between the electrodes 502, 503 and electrodes 504, 505.
  • the piezoelectric substrate 506 is preferably driven in its fundamental (being in this case 8.611 MHz) surface acoustic wave (Rayleigh) mode of vibration.
  • Figure 7 shows a more detailed schematic of one of the left-hand upper pads 602 from Figure 6.
  • the interlaced fingers are evenly spaced, with 110- micron wide fingers and 110-micron wide gaps between the fingers.
  • Excitation of the electrodes with a signal of ultrasonic frequencies generates surface acoustic waves that travel along the surface of the lithium niobate substrate 506.
  • a liquid droplet is applied to the excited surface of the substrate 506 in an arrangement identical to that shown in Figure 1 , thereby generating nanoparticles of fluid as described above for the first embodiment.
  • Figure 8 is an enlarged image of the lower left-hand electrode pair 610 of the mask shown in Figure 6. It will be apparent from Figure 6 that the lower set of electrodes 610, 612 are different from the other electrodes 602 on the mask. While the upper three sets of electrodes 602 are of a relatively simple and symmetrical design, and are all identical to each other, the two lower electrodes 610, 612 are more complex and are asymmetrical. Additionally, these two electrodes 610, 612 are not identical to each other but rather are mirror images of each other. This arrangement cancels out the left-ward propagation of the generated wave in the left electrode pair 610; and correspondingly, the right-ward propagation of the generated wave in the right electrode pair 612.
  • the electrode pairs are therefore unidirectional, generating SAW radiation in only one direction.
  • An additional feature of these electrodes 610, 612 is the ability to efficiently excite harmonic overtones of the fundamental resonance frequency of the electrode pattern which lies at approximately 10 MHz, permitting the use of higher- frequency resonances to atomize fluids placed between the two electrode pairs 610, 612.
  • the transducer element 501 was driven at 8.611 MHz and used to atomise a fluid drop of polycaprolactone (PCL) dissolved at 5% w/v in acetone. As shown in Figure 9, this generates monodisperse particles with a range of diameters narrowly distributed around an average diameter of around 63 nm +/-8.188 nm; 96% of the particles were within this narrow range.
  • the transducer element 501 was again driven at 8.611 MHz at a minimum input power of 2W required for atomising the working fluid. The experiment used a weaker concentration of polycaprolactone (PCL) dissolved at 1% weight per weight (w/w) in acetone.
  • the working fluid was supplied to the transducer element 501 using a syringe pump at a flow rate of 24 mol/hr. It was observed that the atomisation of the working fluid was difficult to achieve when the PCL concentration was higher than 1% w/w. Rapid evaporation of acetone prior to atomisation left a film of polymer which covered the surface of the transducer and consequently damped the capillary waves from where the microdroplets are understood to be generated.
  • the size and shape of the produced nanoparticles were determined using a number of different techniques consisting of Dynamic Light Scattering (DLM), Atomic Force Microscopy (AFM) and Transmission Electron Microscopy (TEM).
  • Figure 10 is a scanning electron micrograph of zeolite particles generated by the SAW atomizer.
  • the agglomerated zeolite particles each have a diameter of about 100 nm.
  • the nanoparticles were generated by atomizing a rather caustic (pH 13) solution of zeolite in 25% ethanol, 50% acetone, and 25% NaOH.
  • the ceramic zeolite dissolves in the caustic solution, but solidifies rapidly on atomization via evaporation of the acetone and ethanol carrier components.
  • the particles are collected on a solid surface and heated at 250 0 C for 15 minutes to remove any residual solvent.

Abstract

A process and apparatus for generating particles, including: applying an ultrasonic signal to at least one electrode (104, 502, 503, 504, 505) of a piezoelectric transducer element (101 , 501) to generate vibrations in said transducer element; and applying a liquid to a surface (108) of said transducer element, said liquid including a particle forming component and a carrier component; whereby the vibration of said transducer element generates droplets of said liquid to form substantially solid particles by evaporation of at least part of said carrier component.

Description

PROCESS AND APPARATUS FOR GENERATING PARTICLES
The present invention relates to a process and apparatus for generating particles.
BACKGROUND OF THE INVENTION
A new generation of therapeutics known as biopharmaceuticals includes biologic drugs, proteins, polynucleotides and liposomes. However, the efficiency of biopharmaceuticals is limited by their generally poor update in the human body. One approach to address the very low cell transection efficiencies of biopharmaceutical is to administer large doses. However, this can lead to unwanted side-effects such as toxicity and multidrug resistance, as well as the economic factors of higher expense per dose and the need for greater biopharmaceutical production. The two steps that limit biopharmaceutical uptake in the body are: (i) the cellular uptake of the biopharmaceutical, and (ii) the migration of the biopharmaceutical into the cell nucleus. Both of these steps are particularly difficult to improve for molecules that are non-soluble, toxic or large. However, the delivery of biopharmaceuticals in nanoparticles, in particular particles having a diameter less than about 250 nm, can assist in overcoming both of these limiting steps. However, existing processes for generating nanoparticles suitable for drug delivery are cumbersome, time consuming, expensive, require the user of organic solvents, and are typically capable of producing only low yields of nanoscale particles. Moreover, the resulting particles can agglomerate into larger clusters shortly after formation, thus reducing the yield of nanoscale particles even further. There is thus a need for a simple process for producing unagglomerated nanoparticles in the absence of organic solvents, which would represent a major breakthrough for drug encapsulation and delivery.
It is desired to provide a process and apparatus for generating particles that alleviate one or more of the above difficulties, or at least provide a useful alternative. SUMMARY OF THE INVENTION
With this in mind, in accordance with one aspect of the present invention, there is provided a process for generating particles, including: applying an ultrasonic signal to at least one electrode of a piezoelectric transducer element to generate vibrations in said transducer element; and applying a liquid to a surface of said transducer element, said liquid including a particle forming component and a carrier component; whereby the vibration of said transducer element generates droplets of said liquid to form substantially solid particles by evaporation of at least part of said carrier component.
Preferably the ultrasonic signal has a frequency of at least about 1 MHz. Preferably, said particles have a diameter of less than about 1000 nm. Preferably, the carrier component is substantially volatile. Preferably, the vibration of said transducer element is such that the formed particles have a substantially monodisperse size distribution.
Advantageously, the transducer element may include electrodes located on opposing surfaces of a piezoelectric material to excite piston mode vibration of said material.
Preferably, said vibration is at a frequency of at least about 100 to 500 MHz.
Preferably, said vibration is at a resonance frequency of said material. Alternatively, the transducer element may include the electrodes located on one surface of said material to excite surface acoustic waves in said surface.
The ultrasonic signal applied to the electrode may be at a frequency of at least about 8 MHz.
Preferably, the diameter of said droplets is less than about 6000 nm. Preferably, the diameter of said particles is less than about 250 nm. Preferably, the diameter of said particles is less than about 50 nm. Preferably, said particle forming component of said liquid includes a polymer.
Preferably, said polymer is suitable for drug delivery to a human being. Advantageously, said particle forming component of said liquid may include a metal or ceramic. Advantageously, said liquid may include a drug.
Advantageously, said liquid may include a biopharmaceutical substance.
Advantageously, said particles may include a liquid encapsulated within a solid. The present invention also provides an apparatus for generating particles, including: a transducer element including a piezoelectric material having at least one electrode located on one or more surfaces of said material; a signal generator connected to said electrode to apply an ultrasonic signal to said electrodes, thereby generating vibrations in said material; whereby the vibration of said material generates droplets of a liquid applied to a surface of said material, the liquid including a particle forming component and a carrier component such that the droplets form substantially solid particles by evaporation of at least part of said carrier component. Preferably, the apparatus includes a dispensing component for dispensing said liquid to said surface.
Preferably the ultrasonic signal has a frequency of at least about 1 MHz.
Preferably, said particles have a diameter of less than about 1000 nm.
Preferably, the carrier component is substantially volatile. Preferably, the vibration of said material is such that the formed particles have a substantially monodisperse size distribution.
Advantageously, the electrodes may be on opposing surfaces of said material to excite piston mode vibration of said material.
Preferably, said vibration is at a frequency of at least about 100 to 500 MHz.
Preferably, said vibration is a resonance frequency of said material.
Alternatively, the electrodes may be located on one surface of said material to excite surface acoustic waves in said surface.
The ultrasonic signal applied to the electrode may be at a frequency of at least about 8 MHz.
Preferably, the diameter of said droplets is less than about 6000 nm.
Preferably, the diameter of said particles is less than about 250 nm.
Preferably, the diameter of said particles is less than about 50 nm. Preferably, said particle forming component of said liquid includes a polymer.
Preferably, said polymer is suitable for drug delivery to a human being. Advantageously, said particle forming component of said liquid may include a metal or ceramic.
Advantageously, said liquid may include a drug.
Advantageously, said liquid may include a biopharmaceutical substance.
BRIEF DESCRIPTION OF THE DRAWINGS It will be convenient to further describe the invention with respect to the accompanying drawings which illustrate preferred embodiments of the apparatus according to the present invention. Other embodiments of the invention are possible, and consequently, the particularity of the accompanying drawings is not to be understood as superseding the generality of the preceding description of the invention.
In the drawings:
Figure 1 is a schematic diagram of a preferred embodiment of an apparatus for producing nanoparticles;
Figure 2 is a flow diagram of a preferred embodiment of a process for producing nanoparticles using the apparatus;
Figures 3 and 4 are graphs of particle size distribution produced by the atomizer using vibration velocities of 1.0 and 1.4 m/s, respectively;
Figure 5 is a schematic diagram of a piezoelectric transducer of the SAW atomizer in accordance with a second preferred embodiment of the invention; Figure 6 is an image of a photolithographic mask used to define electrodes of a SAW atomizer in accordance with Figure 5;
Figures 7 and 8 are images of portions of the photolithographic mask used to define pairs of interdigitated electrodes for the SAW atomizer;
Figure 9 is a graph of particle size distribution produced by the SAW atomizer; and
Figure 10 is a scanning electron microscope image of agglomerated particles of zeolite produced by the SAW atomizer, each particle having a diameter of about 100 nm. DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
As shown in Figure 1 , an apparatus for generating particles includes a piezoelectric transducer element 101 in the form of a cylindrical disc 102 of a hard piezoelectric material such as lead zirconate titanate (PZT) and having a diameter of about 20 to 30 mm and a thickness of about 1 mm. The apparatus, also referred to herein as an atomizer, is described herein in relation to an atomization process, as shown in Figure 2, that generates substantially solid particles, via the formation of nanoscale droplets of a liquid that includes a particle forming component and a carrier component.
At step 202, 500-nm thick layers of platinum (Pt) metal are deposited onto the opposing planar faces of the disc 102 to provide electrodes 104 for the atomizer. The PZT disc 102 is then polarized by applying a 20 kV/cm electric field to orient the electric domains within the ceramic PZT disc 102 along the thickness direction of the disc 102. The electrodes 104 are subsequently connected to outputs of respective polarities of a Radio Frequency (RF) signal generator 106. The RF signal generator 106 drives the PZT transducer element 101 with a sinusoidal signal having an ultrasonic frequency of at least about 1 MHz, thereby causing the opposing planar faces of the transducer element 101 to vibrate with a relatively constant and in-phase piston-like motion across each planar face of the transducer element 101. The disk 102 is preferably driven in either its fundamental (being in this case 1.645 MHz) or first harmonic (5.345 MHz) thickness mode of vibration.
At step 204, a drop of a desired fluid is applied to the underside or downward directed face 108 of the transducer element 101 from a syringe 110 or other form of liquid pump, using a supply tube 112 to conduct the fluid from the syringe 110 to the transducer element 101. The liquid applied to the face of the transducer element 101 includes a particle forming component and a carrier component. The particle forming component can be any substance that can be dissolved in the carrier component and that solidifies to a substantial extent upon removal of the carrier component. Examples of suitable particle forming components include polymers, metals, and ceramics. The particle forming component is preferably a polymer, and more preferably a polymer suitable for drug delivery to a human being, being a physiologically acceptable polymer that biodegrades into non-harmful products such as natural metabolites or other materials that can be readily cleared from the body on an acceptable time scale. The liquid can also include chemical and/or biological markers to harness cellular transport mechanisms and thereby increase transfection efficiencies into cells. The liquid may also control the release of an encapsulated drug by selective degradation of the polymer matrix upon injection, ingestion or inhalation.
When the transducer element 101 is excited at an ultrasonic frequency at step 206, the liquid drop 112 on the lower face 108 of the transducer element 102 is atomized, whereby tiny droplets or particles of the liquid are emitted from the surface of the drop 112. The droplets are generated by acoustic radiation transmitted from the PZT element into the liquid applied to the transducer face 108, as described in Robert J. Lang, Ultrasonic atomization of liquids, Journal of the Acoustical Society of America Vol. 34, No. 1 , 1962 ("Lang"). The droplets are believed to be generated by surface capillary waves at low power excitation of the PZT element, and by surface instabilities about the crests of these waves at higher power excitation. By vibrating the transducer element 101 at ultrasonic frequencies of at least about 1 MHz, nanometer-scale droplets can be formed.
The atomized droplets or particles 116 fall a distance 118 (being in this case about 8 cm) under gravity to a capture medium 120 contained in a vessel 122 located under the transducer element 101 at step 208, allowing for evaporation of the carrier component of the liquid within the atomized droplets to form substantially solid or hollow, fluid-containing particles. Depending on the atomization conditions, the particles can be monodisperse with diameters on a nanometer-scale. The capture medium contains chemicals to prevent agglomeration of the formed nanoparticles. In the described embodiment, the capture medium consists of deionized (Dl) water and a hardening agent such as sodium dodecyl sulfate (SDS) at 1 mM, which facilitates the precipitation of the particles 116 in the capture medium 120. The nanoparticle-containing capture medium and hardening agent is then centrifuged at approximately 2500 rpm for 10 minutes in a swinging bucket rotor to remove any large agglomerates that may have formed, due predominantly to accumulation of the hydrophobic polymer at the air-liquid interface. Measurement of the particle size distribution both before and after centrifugation indicates that the distribution and yield of the nanoparticles was unaffected by the centrifuge.
To evaluate the performance of the atomizer, a polymeric solution was prepared by dissolving polycaprolactone (PCL), with a molecular weight of 65 000 Dalton in acetone (99.5% purity) to create a feedstock solution of 0.5% PCL weight per volume (w/v). The feedstock solution pumped onto the face 108 of the transducer element 102 forms a 10-mm diameter droplet with a wetting angle of approximately 30 degrees, maintained through controlled pumping rate of the feedstock solution. The acetone carrier component evaporates very rapidly upon atomization to produce solid particles of the polymer. The resulting particle sizes were measured using a Zetasizer instrument from the UK company Malvern Instruments with Dispersion Technology Software version 4.10b1. The Z-average particle size of each sample is defined as the diameter of the sphere that diffuses at the same speed as the particle being measured. The Malvern system determines Z-average particle size by measuring the Brownian motion of the particles in a sample using dynamic light scattering. The vibration velocity of the surface was monitored using a laser Doppler vibrometer during operation.
Particle size analysis obtained using the Zetasizer are shown, in Table 1 for the ultrasonic atomization of 0.5% polycaprolactone in acetone at approximately 25 C and 45% relative humidity. Unless indicated otherwise in Table 1 , the feedstock solution was pumped at a flow rate of 28 ml/h onto the bottom surface of the piezoelectric disk transducer running at an amplitude of 1.0 m/s vibration velocity and a frequency of 1.645 MHz into a hardening agent of 1 mM SDS in water located 8 cm beneath the transducer. Under most conditions, as shown in Table 1 , an average particle diameter was found to be between 181 and 226 nm.
Table 1
Z-Average Particle Standard Number
Parameter Diameter Deviation of runs
Transducer 0.7 m/s 208 5.7 6
Vibration 1.0 m/s 186 5.7 6
Velocity 1.4 m/s 5641 6474.4 6
Excitation 1.645 MHz 186 5.7 6
Frequency 5.305 MHz 182 2.3 6
Flow rate 20 ml/hr 187 13.9 6
28 ml/hr 186 5.7 6
36 ml/hr 181 6.5 6
Atomizer height 8 cm 186 8.4 3
12 cm 202 3.5 3
16 cm 215 4.6 3
SDS Detergent 1 mM 186 5.7 6
Concentration 1O mM 226 21.4 6
10O mM 3467 3692.7 6
Figure 3 is a log-linear graph of the particle size frequency distribution under the conditions which resulted in the smallest Z- average particle size observed, 181 nm, with a standard deviation (σ) of 6.5 nm. The distribution in
Figure 3 is essentially a monodisperse, symmetrical (on a log-linear scale) frequency distribution 302. A small amount of larger agglomerations 304 which were not removed by the centrifuge are visible in the graph at diameters of approximately 500 to 700 nm.
Figure 4 is a graph of the bimodal particle size frequency distribution that was obtained when the vibration velocity was increased to 1.4 m/s. The reduced efficiency of the atomisation process may be caused by overheating of the liquid, causing it to boil away, or by the ejection of far larger droplets from the surface of the drop 114 than at the lower vibration velocity of 1.0 m/s.
The efficiency of the atomisation process is also reduced if the concentration of SDS in the capture solution hardening agent is increased to 100 mM. It is believed that the hydrophobic nature of the polymer prevents the creation of a stable emulsification in water, and hence a surfactant is added to assist in stabilizing the nanoparticle/hardening agent solution. The critical micelle concentration (CMC) of SDS in water is approximately 2.5 g/l or 8.7 mM. It was observed that, at concentrations below and above the CMC of SDS in water, e.g. 1 mM and 10 mM, no sedimentation of the nanoparticles occurred. At much higher SDS concentrations, e.g. 100 mM or 11.5 CMC, the particles tended to form larger aggregates that varied greatly in size, as indicated by the larger Z- average particle diameter and larger standard deviation in column 3 of Table 1.
Analysis of variance (ANOVA) studies were performed for each of the process parameters of frequency, amplitude, flow rate, atomizer height and detergent concentration in the hardening agent. The ANOVA analysis (not shown) indicated that, for the conditions listed in Table 1 , the parameters of amplitude, atomizing surface height and surfactant concentration in the hardening agent have statistically significant effects on the Z-average particle diameter of the PCL nanoparticles, using p = 0.05. In contrast, variations in the flow rate and frequency do not have statistically significant effects on the Z-average particle diameter (p = 0.05).
In an alternative embodiment, nanoparticles of fluid are generated by surface acoustic waves on the surface of a piezoelectric transducer, as described in M. Kurosawa, A. Futami, and T. Higuchi, Characteristics of Liquids Atomization Using Surface Acoustic Wave, Proc. of Transducer 97, Chicago, USA ("Kurosawa"), rather than by piston movement of the entire transducer, as described above. As shown in Figure 5, in this alternative embodiment, the transducer element 501 includes four interdigitated finger electrode pairs 502,
503, 504, 505 are formed on the surface of a generally parallelepiped piezoelectric substrate 506. The substrate 506 is cut from a 128 Y-X rotated
LiNbO3 crystal wafer sourced from Roditi UK, Ltd. The four electrodes 502, 503,
504, 505 form two pairs of electrically isolated and interdigitated or interleaved finger electrodes. Electrodes 502 and 503 are connected to respective polarity outputs of the signal generator 106, with the other pair of electrodes 504, 505 being left disconnected, short-circuited, or also connected to the signal generator 106 in the same manner as the first pair pf electrodes 502, 503 to obtain different forms of wave vibration along the crystal surface. The electrodes are defined by photolithography using the quartz mask shown in Figure 6. The mask defines four sets of electrode pairs and thus can be used to produce four surface acoustic wave (SAW) atomizers. The horizontal direction in Figure 6 corresponds to the Y-axis of the LiNbO3 wafer. The upper three rows of electrode pairs, as seen in Figure 6, are identical and define a simple interdigitated electrode pair configuration as shown in Figure 5. Each electrode is formed by depositing a 5-nm thick adhesion layer of titanium followed by a 250-nm-thick layer of aluminium. The black boxes 604 around the periphery of the mask are used to align cutting lines; the corner boxes 606 demarcate the sides of the top and bottom atomizers and ends of all four atomizers. The smaller boxes 604 along the left and right sides demarcated the dividing lines between the atomizers. Wires (not shown) are attached to the upper and lower bars 608 of each pair of interdigitated finger electrodes to conduct the ultrasonic driving signals to each of the electrode fingers. With respect to the vertical direction of Figure 6, the Rayleigh waves are essentially isolated to the region where the fingers overlap, and propagate in both directions from each electrode pair. Reflection of the Rayleigh wave generated from the electrodes off the left and right edges is reduced by coating the edges of the LiNbOs crystal with silicone rubber. The left electrode pair and right electrode pair are used together to form
(Rayleigh) surface acoustic waves (SAW) that propagate from one electrode pair to the other electrode pair. These waves are formed by the inverse piezoelectric effect among the fingers of each electrode pair, where a differential charge between fingers causes distortion of the surface at a speed which matches the speed of sound of the Rayleigh wave divided by the distance between the IDT fingers. For example, the speed of sound of Rayleigh wave along the y-axis of 128 Y-X LiNbO3 material is 5112 m/s, and four times the 110-micron inter-finger width is 440 microns, giving a frequency of 11.6 MHz. The RF signal generator 106 drives the lithium niobate element 506 with a sinusoidal signal having an ultrasonic frequency of at least about 1 MHz, thereby causing the planar faces of the transducer element 506 to vibrate with a relatively constant sinusoidal motion between and within electrodes 502 to 505, perpendicular to the planar face and along a direction between the electrodes 502, 503 and electrodes 504, 505. The piezoelectric substrate 506 is preferably driven in its fundamental (being in this case 8.611 MHz) surface acoustic wave (Rayleigh) mode of vibration.
Figure 7 shows a more detailed schematic of one of the left-hand upper pads 602 from Figure 6. The interlaced fingers are evenly spaced, with 110- micron wide fingers and 110-micron wide gaps between the fingers.
Excitation of the electrodes with a signal of ultrasonic frequencies generates surface acoustic waves that travel along the surface of the lithium niobate substrate 506. A liquid droplet is applied to the excited surface of the substrate 506 in an arrangement identical to that shown in Figure 1 , thereby generating nanoparticles of fluid as described above for the first embodiment.
Figure 8 is an enlarged image of the lower left-hand electrode pair 610 of the mask shown in Figure 6. It will be apparent from Figure 6 that the lower set of electrodes 610, 612 are different from the other electrodes 602 on the mask. While the upper three sets of electrodes 602 are of a relatively simple and symmetrical design, and are all identical to each other, the two lower electrodes 610, 612 are more complex and are asymmetrical. Additionally, these two electrodes 610, 612 are not identical to each other but rather are mirror images of each other. This arrangement cancels out the left-ward propagation of the generated wave in the left electrode pair 610; and correspondingly, the right-ward propagation of the generated wave in the right electrode pair 612. The electrode pairs are therefore unidirectional, generating SAW radiation in only one direction. An additional feature of these electrodes 610, 612 is the ability to efficiently excite harmonic overtones of the fundamental resonance frequency of the electrode pattern which lies at approximately 10 MHz, permitting the use of higher- frequency resonances to atomize fluids placed between the two electrode pairs 610, 612.
To illustrate the performance of the SAW atomizer, the transducer element 501 was driven at 8.611 MHz and used to atomise a fluid drop of polycaprolactone (PCL) dissolved at 5% w/v in acetone. As shown in Figure 9, this generates monodisperse particles with a range of diameters narrowly distributed around an average diameter of around 63 nm +/-8.188 nm; 96% of the particles were within this narrow range. In another experiment, the transducer element 501 was again driven at 8.611 MHz at a minimum input power of 2W required for atomising the working fluid. The experiment used a weaker concentration of polycaprolactone (PCL) dissolved at 1% weight per weight (w/w) in acetone. The working fluid was supplied to the transducer element 501 using a syringe pump at a flow rate of 24 mol/hr. It was observed that the atomisation of the working fluid was difficult to achieve when the PCL concentration was higher than 1% w/w. Rapid evaporation of acetone prior to atomisation left a film of polymer which covered the surface of the transducer and consequently damped the capillary waves from where the microdroplets are understood to be generated. The size and shape of the produced nanoparticles were determined using a number of different techniques consisting of Dynamic Light Scattering (DLM), Atomic Force Microscopy (AFM) and Transmission Electron Microscopy (TEM). The results showed that nanoparticles of two different diameters were generated smaller than 50 nm and 130-220 nm. The results from the AFM imaging indicated that the larger nanoparticles might be agglomerations of nanoparticles smaller than 50 nm, although this finding does not appear to be supported by the DLS and TEM data. For studies are therefore required in this area.
Figure 10 is a scanning electron micrograph of zeolite particles generated by the SAW atomizer. The agglomerated zeolite particles each have a diameter of about 100 nm. The nanoparticles were generated by atomizing a rather caustic (pH 13) solution of zeolite in 25% ethanol, 50% acetone, and 25% NaOH. The ceramic zeolite dissolves in the caustic solution, but solidifies rapidly on atomization via evaporation of the acetone and ethanol carrier components. The particles are collected on a solid surface and heated at 2500C for 15 minutes to remove any residual solvent.
Modifications and variations as would be deemed obvious to the person skilled in the art are included within the ambit of the present invention as claimed in the appended claims.

Claims

CLAIMS:
1. A process for generating particles, including: applying an ultrasonic signal to at least one electrode of a piezoelectric transducer element to generate vibrations in said transducer element; and applying a liquid to a surface of said transducer element, said liquid including a particle forming component and a carrier component; whereby the vibration of said transducer element generates droplets of said liquid to form substantially solid particles by evaporation of at least part of said carrier component.
2. A process according to claim 1 , wherein the ultrasonic signal has a frequency of at least about 1 MHz.
3. A process according to claim 1 or 2, wherein said particles have a diameter of less than about 1000 nm.
4. A process according to any one of the preceding claims, wherein the carrier component is substantially volatile.
5. A process according to any one of the preceding claims, wherein the vibration of said transducer element is such that the formed particles have a substantially monodisperse size distribution.
6. A process according to any one of the preceding claims, wherein the transducer element includes electrodes located on opposing surfaces of a piezoelectric material to excite piston mode vibration of said material.
7. A process according to claim 6, wherein said vibration is at a frequency of at least about 100 to 500 MHz.
8. A process according to claim 6, wherein said vibration is at a resonance frequency of said material.
9. A process according to any one of claims 1 to 5, wherein the transducer element includes at least one electrode located on one surface of said material to excite surface acoustic waves in said surface.
10. A process according to claim 9, wherein the ultrasonic signal applied to the electrode is at a frequency of at least about 8 MHz.
11. A process according to any one of the preceding claims, wherein the diameter of said droplets is less than about 6000 nm.
12. A process according to any one of claims 1 to 11 , wherein the diameter of said particles is less than about 250 nm.
13. A process according to claim 12, wherein the diameter of said particles is less than about 50 nm.
14. A process according to any one of the preceding claims, wherein said particle forming component of said liquid includes a polymer.
15. A process according to claim 14, wherein said polymer is suitable for drug delivery to a human being.
16. A process according to any one of the preceding claims, wherein said particle forming component of said liquid includes a metal or ceramic.
17. A process according to any one of the preceding claims, wherein said liquid includes a drug.
18. A process according to any one of the preceding claims, wherein said liquid includes a biopharmaceutical substance.
19. A process according to any one of the preceding claims, wherein said particles include a liquid encapsulated within a solid.
20. An apparatus for generating particles, including: a transducer element including a piezoelectric material having at least one electrode located on one or more surfaces of said material; a signal generator connected to said electrodes to apply an ultrasonic signal to said electrodes, thereby generating vibrations in said material; whereby the vibration of said material generates droplets of a liquid applied to a surface of said material, the liquid including a particle forming component and a carrier component such that the droplets form substantially solid particles by evaporation of at least part of said carrier component.
21. An apparatus according to claim 20, wherein the apparatus includes a dispensing component for dispensing said liquid to said surface.
22. An apparatus according to claim 20 or 21 , wherein the ultrasonic signal has a frequency of at least about 1 MHz.
23. An apparatus according to any one of claims 20 to 22, wherein said particles have a diameter of less than about 1000 nm.
24. An apparatus according to any one of claims 20 to 23, wherein the carrier component is substantially volatile.
25. An apparatus according to any one of claims 20 to 24, wherein the vibration of said material is such that the formed particles have a substantially monodisperse size distribution.
26. An apparatus according to any one of claims 20 to 25, wherein the electrodes are on opposing surfaces of said material to excite piston mode vibration of said material.
27. An apparatus according to claim 26, wherein said vibration is at a frequency of at least about 100 to 500 MHz.
28. An apparatus according to claim 26, wherein said frequency is a resonance frequency of said material.
29. An apparatus according to any one of claims 20 to 25, wherein the electrodes is located on one surface of said material to excite surface acoustic waves in said surface.
30. An apparatus according to claim 29, wherein the ultrasonic signal applied to the electrode is at a frequency of at least about 8 MHz.
31. An apparatus according to any one of claims 20 to 30, wherein the diameter of said droplets is less than about 6000 nm.
32. An apparatus according to any one of claims 20 to 31 , wherein the diameter of said particles is less than about 250 nm.
33. An apparatus according to claim 32, wherein the diameter of said particles is less than about 50 nm.
34. An apparatus according to any one of claims 20 to 33, wherein said particle forming component of said liquid includes a polymer.
35. An apparatus according to claim 34, wherein said polymer is suitable for drug delivery to a human being.
36. An apparatus according to any one of claims 20 to 35, wherein said particle forming component of said liquid includes a metal or ceramic.
37. An apparatus according to any one of claims 20 to 36, wherein said liquid includes a drug.
38. An apparatus according to any one of claims 20 to 37, wherein said liquid includes a biopharmaceutical substance.
PCT/AU2006/001951 2005-12-21 2006-12-20 Process and apparatus for generating particles WO2007070957A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005907181 2005-12-21
AU2005907181A AU2005907181A0 (en) 2005-12-21 Process and Apparatus for Generating Particles

Publications (1)

Publication Number Publication Date
WO2007070957A1 true WO2007070957A1 (en) 2007-06-28

Family

ID=38188165

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2006/001951 WO2007070957A1 (en) 2005-12-21 2006-12-20 Process and apparatus for generating particles

Country Status (1)

Country Link
WO (1) WO2007070957A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1930071A1 (en) * 2006-12-06 2008-06-11 ECKA Granulate GmbH & Ko. KG Method for producing particles from flowable material and atomisation equipment therefor
ITPD20090249A1 (en) * 2009-09-02 2011-03-03 Fond Carlo E Dirce Callerio O Nlus METHOD AND APPARATUS FOR THE PREPARATION OF POLYSACCHARID MICRO-PARTICLES
WO2016118704A1 (en) * 2015-01-21 2016-07-28 Melior Innovations, Inc. Methods of manufacturing polymer derived ceramic particles
US9481781B2 (en) 2013-05-02 2016-11-01 Melior Innovations, Inc. Black ceramic additives, pigments, and formulations
FR3043576A1 (en) * 2015-11-18 2017-05-19 Areco Finances Et Tech - Arfitec MINIATURIZED SPRAY DEVICE WITH PIEZOELECTRIC TRANSDUCER
US9657409B2 (en) 2013-05-02 2017-05-23 Melior Innovations, Inc. High purity SiOC and SiC, methods compositions and applications
US9828542B2 (en) 2013-03-15 2017-11-28 Melior Innovations, Inc. Methods of hydraulically fracturing and recovering hydrocarbons
CN110961031A (en) * 2019-11-29 2020-04-07 淮阴工学院 Non-contact micro/nano particle control method
US10836682B2 (en) 2017-07-22 2020-11-17 Melior Innovations, Inc. Methods and apparatus for conducting heat exchanger based reactions
US11311686B2 (en) 2014-11-11 2022-04-26 The University Court Of The University Of Glasgow Surface acoustic wave device for the nebulisation of therapeutic liquids

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62149331A (en) * 1985-12-21 1987-07-03 Shinryo Air Conditioning Co Ltd Device for generating particle having optional diameter
EP0512394A2 (en) * 1991-05-02 1992-11-11 Waters Investments Limited Method and apparatus for analyzing sample solutions
US5297734A (en) * 1990-10-11 1994-03-29 Toda Koji Ultrasonic vibrating device
US5389379A (en) * 1992-02-18 1995-02-14 Akzo N.V. Process for the preparation of biologically active material containing polymeric microcapsules
US6601581B1 (en) * 2000-11-01 2003-08-05 Advanced Medical Applications, Inc. Method and device for ultrasound drug delivery
EP1452239A1 (en) * 2001-11-05 2004-09-01 Riken Immobilizing device

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62149331A (en) * 1985-12-21 1987-07-03 Shinryo Air Conditioning Co Ltd Device for generating particle having optional diameter
US5297734A (en) * 1990-10-11 1994-03-29 Toda Koji Ultrasonic vibrating device
EP0512394A2 (en) * 1991-05-02 1992-11-11 Waters Investments Limited Method and apparatus for analyzing sample solutions
US5389379A (en) * 1992-02-18 1995-02-14 Akzo N.V. Process for the preparation of biologically active material containing polymeric microcapsules
US6601581B1 (en) * 2000-11-01 2003-08-05 Advanced Medical Applications, Inc. Method and device for ultrasound drug delivery
EP1452239A1 (en) * 2001-11-05 2004-09-01 Riken Immobilizing device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1930071A1 (en) * 2006-12-06 2008-06-11 ECKA Granulate GmbH & Ko. KG Method for producing particles from flowable material and atomisation equipment therefor
ITPD20090249A1 (en) * 2009-09-02 2011-03-03 Fond Carlo E Dirce Callerio O Nlus METHOD AND APPARATUS FOR THE PREPARATION OF POLYSACCHARID MICRO-PARTICLES
WO2011026896A1 (en) * 2009-09-02 2011-03-10 Fondazione Carlo E Dirce Callerio Onlus Method and apparatus for preparing micro-particles of polysaccharides
US8545739B2 (en) 2009-09-02 2013-10-01 Moreno Cocchietto Method and apparatus for preparing micro-particles of polysaccharides
US9828542B2 (en) 2013-03-15 2017-11-28 Melior Innovations, Inc. Methods of hydraulically fracturing and recovering hydrocarbons
US9481781B2 (en) 2013-05-02 2016-11-01 Melior Innovations, Inc. Black ceramic additives, pigments, and formulations
US9657409B2 (en) 2013-05-02 2017-05-23 Melior Innovations, Inc. High purity SiOC and SiC, methods compositions and applications
US11311686B2 (en) 2014-11-11 2022-04-26 The University Court Of The University Of Glasgow Surface acoustic wave device for the nebulisation of therapeutic liquids
US11771846B2 (en) 2014-11-11 2023-10-03 The University Court Of The University Of Glasgow Nebulisation of liquids
WO2016118704A1 (en) * 2015-01-21 2016-07-28 Melior Innovations, Inc. Methods of manufacturing polymer derived ceramic particles
FR3043576A1 (en) * 2015-11-18 2017-05-19 Areco Finances Et Tech - Arfitec MINIATURIZED SPRAY DEVICE WITH PIEZOELECTRIC TRANSDUCER
US10836682B2 (en) 2017-07-22 2020-11-17 Melior Innovations, Inc. Methods and apparatus for conducting heat exchanger based reactions
CN110961031A (en) * 2019-11-29 2020-04-07 淮阴工学院 Non-contact micro/nano particle control method

Similar Documents

Publication Publication Date Title
WO2007070957A1 (en) Process and apparatus for generating particles
Friend et al. Evaporative self-assembly assisted synthesis of polymeric nanoparticles by surface acoustic wave atomization
Yeo et al. Ultrafast microfluidics using surface acoustic waves
Chattopadhyay et al. Production of antibiotic nanoparticles using supercritical CO2 as antisolvent with enhanced mass transfer
Alvarez et al. Rapid generation of protein aerosols and nanoparticles via surface acoustic wave atomization
US20040026804A1 (en) Generation of nanoparticles and microparticles of controllable size using acoustic and ultrasonic vibration
Alvarez et al. Surface vibration induced spatial ordering of periodic polymer patterns on a substrate
US11857992B2 (en) Acoustic wave microfluidic devices with increased acoustic wave energy utilisation
JP5860395B2 (en) A microfluidic device for liquid atomization
Chang et al. A new method for the preparation of monoporous hollow microspheres
Yang et al. Very small bubble formation at the solid− water interface
Alvarez et al. Rapid production of protein-loaded biodegradable microparticles using surface acoustic waves
JP2014042906A (en) Apparatus for producing fine particle, method for producing fine particle, and toner obtained by the method
WO2004074172A1 (en) Fixing method, fixing apparatus and method for producing microstructure
BR112020009373A2 (en) particles for use in acoustic standing wave processes
Homede et al. Signatures of van der Waals and Electrostatic Forces in the Deposition of Nanoparticle Assemblies
Steinacher et al. Spray-assisted formation of micrometer-sized emulsions
Ghafouri et al. Interfacial targeting of sessile droplets using electrospray
Bagheri-Tar et al. Preparation of polyetherimide nanoparticles by an electrospray technique
JP7092974B2 (en) Resin fine particle manufacturing method and resin fine particle manufacturing equipment
JP5891320B1 (en) Processing method using zeta potential control method
Koda et al. Sonochemical Engineering Processes
Qi et al. Investigation of SAW atomization
Yeo et al. Fast inertial microfluidic actuation and manipulation using surface acoustic waves
Matsuyama et al. Coacervation microencapsulation of talc particles with poly (methyl methacrylate) by pressure-induced phase separation of CO2-expanded ethanol solutions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06828055

Country of ref document: EP

Kind code of ref document: A1